Financials
Financial year 2025
European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases from Liège, company number BE0877737261, closed financial year 2025 with a result of € 192,368 after tax. For that financial year European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases recorded a gross margin of € 280,686 and equity of € 795,470. Compared with financial year 2024, the result moved from € -84,942 to € 192,368. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 4, 2026.
€ 795,470
▲ 32% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 192,368
▲ still € 84,942 loss in 2024
Profit after tax over the fiscal year.
€ 552,062
▲ 72% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
€ 60,354
▲ 2% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 19,545
▲ 158% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 8,638
▲ 3% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -15,239 | € -381,723 | € -29,382 | € 280,686 | ▲ € 310,068 |
| Profit after taxes | € -56,422 | € -452,254 | € -84,942 | € 192,368 | ▲ € 277,311 |
| Equity | € 1,140,298 | € 688,044 | € 603,102 | € 795,470 | ▲ 32% |
| Total debts | € 49,951 | € 32,971 | € 15,934 | € 28,183 | ▲ 77% |
| Cash | € 864,412 | € 372,435 | € 321,302 | € 552,062 | ▲ 72% |
| Retained profit | € 1,140,298 | € 688,044 | € 603,102 | € 795,470 | ▲ 32% |
| Balance sheet total | € 1,190,249 | € 721,015 | € 619,036 | € 823,653 | ▲ 33% |
Key figures of European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases?
What happened at European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 192,368. Source: NBB ↗
- Nicholas Fuggle became a director. NBB
- Sansin Tuzun became a director. NBB
- Nicholas Harvey became a director. NBB
- Stefania Maggi became a director. NBB
- Radmila Matijevic became a director. NBB
- Nicola Veronese became a director. NBB
- Charlotte Beaudart became a director. NBB
In short
From € 56,422 loss in 2022 to € 192,368 profit in 2025.
Best year ever: 2025, with € 192,368 profit.
Management
Behind European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases are Jean-Yves Reginster, René Rizzoli, Nicholas Fuggle, Jean-Marc Kaufman, Olivier Bruyère and Maria-Luisa Brandi. Jean-Marc Kaufman is also behind CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTE.
Directors
According to the 2025 annual accounts
Jean-Yves Reginster
Chairman of the board
since 2005
René Rizzoli
Director
since 2007
Nicholas Fuggle
Director
since 2024
Jean-Marc Kaufman
Director
Also active at: CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTE
since 2005
Olivier Bruyère
Managing director
since 2014
Maria-Luisa Brandi
Director
since 2009
Cyrus Cooper
Vice-chairman of the board
since 2011
Stefania Maggi
Director
since 2022
Nicholas Harvey
Director
since 2023
Radmila Matijevic
Director
since 2022
since 2017
Nicola Veronese
Director
since 2022
Sansin Tuzun
Director
since 2024
Charlotte Beaudart
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Quai Godefroid-Kurth 13
4020 Liège
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0877.737.261
- VAT number
- BE 0877.737.261
- Registered office
- Quai Godefroid-Kurth 13, 4020 Liège
- Names & denominations
- European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases · ESCEO
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 6 December 2005
- Peppol
- Active · Active since 22 Sept 2026
- Activities · NACE
Organisatie van congressen en beurzen
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering